OXGN Balance Sheets
(Quarterly, GAAP in millions $) |
(Sep 30 2018)
III. Quarter |
(Jun 30 2018)
II. Quarter |
(Mar 31 2018)
I. Quarter |
(Dec 31 2017)
IV. Quarter |
(Sep 30 2017)
III. Quarter |
|
ASSETS |
| Cash & cash equivalent |
1.06 |
1.97 |
0.23 |
1.12 |
1.91 |
| Restricted Cash and Cash Equivalents, Current |
- |
- |
- |
- |
- |
| Short-term Investments, Total |
- |
- |
- |
- |
- |
| Marketable Securities |
- |
- |
- |
- |
- |
| Other Short-term Investments |
- |
- |
- |
- |
- |
| Investments Total |
- |
- |
- |
- |
- |
| Cash
& Shortterm Investments |
1.06 |
1.97 |
0.23 |
1.12 |
1.91 |
| Accounts receivable |
- |
- |
- |
- |
- |
| Other Receivables |
- |
- |
- |
- |
- |
| Notes Receivable, Current |
- |
- |
- |
- |
- |
| Inventories |
- |
- |
- |
- |
- |
| Derivatives, Collaterals, Regulatory, Deferred Assets |
- |
- |
- |
- |
- |
| Discontinued Operations, Current |
- |
- |
- |
- |
- |
| Other Current Assets |
- |
- |
- |
- |
0.26 |
| Income Taxes, Current |
- |
- |
- |
- |
- |
| Prepaid Expense And Other Assets Current |
0.09 |
0.10 |
0.17 |
0.02 |
0.77 |
| Total Current Assets |
1.15 |
2.07 |
0.40 |
1.14 |
2.94 |
| Equipment/Property/Plant Net |
- |
- |
- |
0.00 |
0.00 |
| Goodwill net |
- |
- |
- |
- |
- |
| Intangible Assets |
- |
- |
- |
- |
- |
| Long-term investments |
- |
- |
- |
- |
- |
| Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
| Financial Instruments |
- |
- |
- |
- |
- |
| Tax Assets, Noncurrent |
- |
- |
- |
- |
- |
| Other Assets, Noncurrent |
- |
0.03 |
0.03 |
0.03 |
0.03 |
| Deferred, Prepaid and Other Assets, Noncurrent |
- |
- |
- |
- |
- |
| Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
| Total Assets |
1.15 |
2.10 |
0.44 |
1.17 |
2.98 |
| LIABILITIES |
| Accounts Payable, Current AC |
0.77 |
1.22 |
1.16 |
0.79 |
0.31 |
| Accrued Liabilities, Current |
0.22 |
0.21 |
0.27 |
0.35 |
0.81 |
| Financial Instruments |
- |
- |
- |
- |
- |
| Shortterm Debt |
- |
- |
- |
- |
- |
| Other Liabilities, Current |
- |
- |
- |
- |
- |
| Taxes Payable |
- |
- |
- |
- |
- |
| Deferred Liability and Revenue |
- |
- |
- |
- |
- |
| Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
| Accrued Clinical Trial Expenses |
0.10 |
0.13 |
0.09 |
0.51 |
0.09 |
| Total Current Liabilities |
1.09 |
1.56 |
1.52 |
1.65 |
1.21 |
| Long-term debt |
- |
- |
- |
- |
- |
| Capital Lease and Other |
- |
- |
- |
- |
- |
| Long-term Debt Convertible |
- |
- |
- |
- |
- |
| Total
Long-term Debt |
- |
- |
- |
- |
- |
| Derivative Liability, Noncurrent DE |
- |
- |
- |
- |
- |
| Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
| Deferred credits, Noncurrent |
- |
- |
- |
- |
- |
| Accrued Income Taxes, Noncurrent |
- |
- |
- |
- |
- |
| Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
| Other liabilities, Noncurrent |
- |
0.00 |
- |
- |
- |
| Total Liabilities |
1.09 |
1.56 |
1.52 |
1.65 |
1.21 |
SHAREHOLDER'S EQUITY |
| Common Stock Value |
0.41 |
0.41 |
0.27 |
0.27 |
0.27 |
| Additional Paid In Capital Common Stock |
294.03 |
293.84 |
291.72 |
291.53 |
291.34 |
| Retained Earnings / Accumulated Deficit |
-294.39 |
-293.71 |
-293.07 |
-292.28 |
-289.84 |
| Other Equity |
0.00 |
0.00 |
0.00 |
-0.00 |
0.00 |
| Noncontrolling interests & other |
- |
- |
- |
- |
- |
| Total
Stockholder's Equity |
0.06 |
0.54 |
-1.09 |
-0.48 |
1.76 |
| Liabilities & Stockholder's
Equity |
1.15 |
2.10 |
0.44 |
1.17 |
2.98 |
